^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Prosigna™ Breast Cancer Prognostic Gene Signature Assay

Type:
FDA Approved
Related tests:
over1year
Clinical
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor)
|
HER-2 negative
|
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
over1year
Combination therapy • Clinical
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative
|
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
over1year
Combination therapy
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive
|
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
|
Herceptin (trastuzumab) • Tecentriq (atezolizumab) • vinorelbine tartrate
over1year
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive • HR positive • HER-2 negative • HR positive + HER-2 negative
|
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
|
Keytruda (pembrolizumab) • paclitaxel
over1year
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
over1year
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
over2years
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 negative
|
Prosigna™ Breast Cancer Prognostic Gene Signature Assay